London scientists find cancer tumours in terminally ill patients are eradicated by herpes virus

An early trial at the Institute for Cancer Research (ICR) in London revealed that a modified version of the herpes simplex virus showed signs of effectiveness.An early trial at the Institute for Cancer Research (ICR) in London revealed that a modified version of the herpes simplex virus showed signs of effectiveness.Read MoreHealth News | Mail Online